Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cingal 17-02 extension study for knee osteoarthritis
2017-003205-18Phase 3Completed
- Sponsor
- Anika Therapeutics
- Start
- Nov 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone hexacetonide + hyaluronic acid, triamcinolone hexacetonide in knee osteoarthritis (OA), sponsored by Anika Therapeutics. Started Nov 2017; status: completed.
02
Drugs
triamcinolone hexacetonide + hyaluronic acidtriamcinolone hexacetonide
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2017-003205-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003205-18.